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Axonal branching in lateral 
olfactory tract is promoted by Nogo 
signaling
Masumi Iketani1,*, Takaakira Yokoyama1,2,*, Yuji Kurihara1, Stephen M. Strittmatter3, 
Yoshio Goshima4, Nobutaka Kawahara2 & Kohtaro Takei1
Mitral cells are major projection neurons of the olfactory bulb (OB) that form an axonal bundle known as 
the lateral olfactory tract (LOT). After axonal bundle formation, collateral branches sprout from primary 
axons of the LOT. Recently, we identified LOT usher substance (LOTUS) as an endogenous Nogo 
receptor-1 (NgR1) antagonist and demonstrated that LOTUS contributes to the formation of the LOT 
axonal bundle. Immunoblots revealed that the expression level of Nogo-A in the OB developmentally 
increased during axonal collateral formation. Next, we found that the axonal collateral branches were 
increased in cultured OB neurons from LOTUS-knockout (KO) mice, whereas they were decreased in 
cultured OB neurons from NgR1-KO mice. Knockdown of Nogo-A in cultured OB neurons reduced the 
number of axonal collateral branches, suggesting that endogenous Nogo-A induces axonal branching. 
Finally, the collateral branches of the LOT were increased in LOTUS-KO mice, whereas those in 
NgR1-KO mice were decreased. Moreover, the abnormal increase of axonal branching observed in 
LOTUS-KO mice was rescued in the double mutant of LOTUS- and NgR1-KO mice. These findings 
suggest that Nogo-A and NgR1 interactions may contribute to axonal branching in LOT development.
The olfactory bulb (OB) is the first relay for olfactory information. It receives sensory inputs from olfactory 
receptor neurons and processes this information before sending it to the olfactory cortex. During devel-
opment, axons from the olfactory receptor neurons exit the olfactory epithelium and grow towards the OB 
anlage1, where they synapse on the dendrites of mitral and tufted cells. These cells project axons into a very 
narrow part of the telencephalon, and their axons form a fasciculated axonal bundle known as the lateral olfac-
tory tract (LOT). The developing LOT grows away from the midline, extends laterally and elongates caudally 
at the surface of the telencephalon2,3. The axons of early-generated mitral and tufted cells emerge from the OB 
at embryonic day (E) 12 in the mouse, and the main shaft of the LOT is formed during the following 2 days. 
After that, collateral branches sprout from the primary axons of the LOT4,5. These collateral branches invade 
in a precise rostro-caudal order, successively entering the anterior olfactory nucleus, piriform and entorhinal 
cortex, olfactory tubercle, and anterior cortical as well as posterolateral nuclei of the amygdala3. These collateral 
branches are the only connections of the mitral and tufted cell axons with the olfactory cortex3,4. Recent studies 
have revealed some of the molecular mechanisms regulating LOT axon guidance and collateral branching5–8. 
Previously, we have reported that LOT usher substance (LOTUS) contributes to LOT axonal bundling through its 
antagonism to the Nogo receptor-1 (NgR1)9. LOTUS is a membrane-bound and/or secreted protein, and NgR1 
is a glycosylphosphatidylinositol-anchored protein10, and they are coordinately expressed on axons of the OB 
neurons9. NgR1 is a common receptor for axonal outgrowth inhibitors such as Nogo10, myelin-associated glyco-
protein (MAG)11, oligodendrocyte myelin glycoprotein (OMgp)12, B-lymphocyte stimulator (BLyS)13 and chon-
droitin sulfate proteoglycans (CSPG)14.
We recently discovered that LOTUS not only inhibited the signaling of Nogo but also MAG, OMgp and 
BLyS through blocking the interactions between these ligands and NgR115. However, the physiological roles of 
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Nogo and NgR1 are not well known in the developing brain. Recent studies have shown that Nogo-A induces 
axonal branching in cultured dorsal root ganglion neurons16 and cultured midbrain neurons17. In contrast, 
exogenous Nogo-A inhibits axonal branching in cultured hippocampal neurons18. Thus, Nogo-NgR1 signaling 
plays a key role in axonal branching of the developing brain. As mentioned above, we previously found that the 
LOTUS-NgR1 interaction induced axonal bundling of LOT through antagonism of NgR1 function9. However, the 
molecular mechanisms of LOT formation, including axonal branching, remain largely unknown. Here, we have 
shown that LOTUS, NgR1 and Nogo-A are expressed in the OB and LOT during the period of axonal branching 
(E16–18) and examined how axonal branching is formed even late in development.
Results
The expression level of Nogo-A increases in the mouse OB during axonal collateral formation 
of the LOT. A previous study reported that collateral branches of the LOT emerge at E164. First, we confirmed 
that collateral branches sprout from the primary axons of the LOT, as visualized by immunohistochemistry with 
the LOT marker molecule Neuropilin-1 (Nrp1) in whole-mount samples of mouse brains (Fig. 1). Collateral 
branches were not observed at E14 (Fig. 1a) but began to sprout from the primary axons of the LOT at E16 
(Fig. 1b) and were elongated at E18 (Fig. 1c). We also examined the expression and distribution of LOTUS in the 
LOT from E14 to E18 with immunohistochemistry and found that LOTUS was distributed in the axonal bundle 
of the LOT from E14 to E18 and the axonal collaterals of the LOT after E16 (Fig. 1d–f).
Previously, we reported that LOTUS, NgR1 and Nogo-A were expressed in OB neurons and the LOT at E12 
and E139. In this study, we examined the expression levels of LOTUS, NgR1 and Nogo-A in the OB after E13 
by immunoblotting. These three molecules were expressed after E13 in the mouse OB. The expression level of 
Nogo-A in the OB significantly increased during axonal collateral formation at E17 and E18 (Fig. 2). In contrast, 
the expression levels of LOTUS and NgR1 remained statistically unchanged, although the expression level of 
LOTUS showed a tendency to increase at E17 and E18 (Fig. 2). Moreover, immunohistochemistry revealed that 
Nogo-A was co-expressed with Tbx21 at E14, 16 and 18 (Fig. 3), which is specifically expressed in mitral and 
tufted cells but not in granular cells19, suggesting that Nogo-A was expressed in the mitral/tufted cell layer of the 
OB from E14 to E18. Because the LOT is formed by axons from mitral and tufted cells20, these results suggest that 
the expression of Nogo-A is developmentally increased from E17 in the LOT.
Knockdown of Nogo-A induces a reduction in collateral branching in cultured OB neurons. We 
have previously reported that LOTUS antagonizes NgR1 signaling9,15. Therefore, we predicted that NgR1 func-
tion is induced by an increase of Nogo-A and that a decrease in LOTUS may be involved in axonal collateral 
branching of the LOT. Then, we examined whether Nogo-A and LOTUS regulate axonal branching in cultured 
OB neurons from E14 mice. Using immunocytochemistry, we first found that all cells expressing Nogo-A were 
Figure 1. Expression of LOTUS in the developing LOT. (a–f) Lateral views of the developing mouse 
forebrain. (a–c) Immunohistochemistry of Nrp1, a LOT marker. Collateral branches (arrowheads) of the LOT 
(arrow) are observed from E16. (d–f) Distribution of LOTUS in the developing mouse forebrain. (d2–f2) are 
higher magnification images of (d1–f1). Scale bar: 1 mm, arrows: LOT, arrowheads: collateral branches of the 
LOT.
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Figure 2. Expression of Nogo-A, NgR1 and LOTUS in the OB. (a) Immunoblots of Nogo-A, NgR1 and 
LOTUS in the olfactory bulb at E14, 15, 16, 17, 18 and P0. WT, LOTUS-KO and NgR1-KO indicate protein 
lysates from wild-type mice at P305, lotus-deficient mice at P237 and ngr1-deficient mice at P91, respectively. 
β -actin is used as an internal control protein. (b) The expression levels of Nogo-A, NgR1 and LOTUS are 
quantified by the intensity of each protein immunoblot and normalized to the intensity of β -actin. The 
significance level was analyzed by performing a Kruskall-Wallis test with Dunn’s multiple comparison analysis. 
(Nogo-A: n = 4 experiments; LOTUS: n = 3 experiments; NgR1: n = 3 experiments).
Figure 3. Expression of Nogo-A in mitral/tufted cell layer of the developing OB. (a–c) Fluorescent 
immunohistochemistry of Tbx21 (a1,b1,c1), Nogo-A (a2,b2,c2) and their merged image with DAPI (a3,b3,c3) 
in the developing OB of wild type mice at E14, 16, and 18. Nogo-A and Tbx21 were co-expressed outside the 
internal granular layer (a3). At E16 and E18, Nogo-A and Tbx21 were co-expressed at the mitral cell layer, 
the external plexiform layer and the glomerular layer (b3,c3). Scale Bars: 100 µ m. Dotted lines are the borders 
between each cell layer. Me: medulla, InGr: internal granular layer, MiCe: mitral cell layer, ExPl: external 
plexiform layer, GlLa: glomerular layer.
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also Tbx21- (mitral and tufted cell marker) and Tau-1-immunopositive (Supplementary Fig. S1), suggesting that 
NogoA is expressed in axons of mitral and tufted cells.
We observed collateral branches of OB neurons for 7 days in vitro and found that the collateral branches 
from lotus-deficient (LOTUS− /− ) mice were increased in comparison to that from wild-type mice (Figs 4a,c,5c), 
whereas the collateral branches from ngr1-deficient (NgR1− /− ) mice were decreased in comparison to wild-type 
mice (Fig. 5a,b,c). These findings suggest that NgR1 function is involved in the collateral branching. Because we 
predicted that NgR1 function induced by an increase in Nogo-A may be involved in axonal collateral branching, 
we next examined whether the increase in collateral branching is induced by Nogo-A signaling. To address this 
issue, we examined the effect of Nogo-A knockdown on collateral branching of cultured OB neurons using lenti-
viral transduction particles encoding shRNA sequences that silence Nogo-A mRNA. We validated the effective-
ness of three Nogo-A shRNAs (sh-Nogo-A: sh1, sh2, sh3) used in these experiments (Supplementary Fig. S2) by 
analyzing Nogo-A-expression intensity with immunostaining (Supplementary Fig. S3). We then regarded cells 
in which the Nogo-A expression level was decreased < 50% as Nogo-A-knocked down cells and analyzed the 
number of axonal branching points in these cells. Because many granule cells in the OB lack an axon, we selected 
the Nogo-A-knocked down cells that were also positive for Tau-1(axonal marker) (Supplementary Fig. S1). The 
axonal branching points were significantly decreased by Nogo-A knockdown in the wild-type neurons (LOTUS+ 
/+ ) (Figs 4b,5c) and in NgR1− /− mice (Fig. 5b,c). Furthermore, axonal branching points were similarly 
decreased by Nogo-A knockdown in LOTUS− /− mice (Figs 4d,5c). Lack of LOTUS (LOTUS− /− ) may suppress 
the antagonistic action to NgR1. It was found that an increase in the axonal branching points was induced by 
endogenous Nogo-A through the binding to NgR1 in neurons from LOTUS− /− mice (Figs 4c,5c). Thus, Nogo 
signaling controlled by LOTUS may regulate axonal collateral branching in the LOT.
We also examined the effects of Nogo-A knockdown by shRNA and genetic ngr1-knockout (NgR1− /− ) 
on axonal growth in cultured OB neurons. As expected, the data showed an increase in axonal growth in 
both Nogo-A knockdown neurons and NgR1− /− neurons (Fig. 5d). These findings suggest that Nogo signa-
ling through the NgR1 appears to inhibit axonal growth but has a different effect on the promotion of axonal 
branching.
Figure 4. Nogo signaling mediates axonal collateral formation in cultured OB neurons. (a1–d1) 
Immunostaining of β III-tubulin, a neuronal marker. (a2–d2) Immunostaining of Tau-1, an axonal marker in the 
same cells of (1). (a3–d3) Merged images of (1) and (2) and (a4–d4) immunostaining of Nogo-A in pseudo-color. 
(a5–d5) Dashed boxes in images of a3–d3 correspond to images of a5–d5 at higher magnification. Arrowheads 
indicate axonal collateral branches. Dissociated OB neurons from E14.5 wild-type mice (LOTUS+ /+ ) (a,b) or 
lotus-deficient mice (LOTUS− /− ) (c,d) were cultured for 7 days. The OB neurons were infected with lentiviral 
particles encoding a shRNA sequence (sh1 in b, sh3 in d) against Nogo-A mRNA (sh-Nogo) (b,d) or lentiviral 
particles encoding a negative control shRNA sequence (NC) (a,c). Compared with that in the LOTUS+ /+ mice 
(NC) (a), axonal branching points were increased (arrowheads in c5) in LOTUS− /− mice (NC) (c), whereas 
knockdown of Nogo-A (sh-Nogo) resulted in reduction in branching points (b,d). Scale bars: 50 µ m.
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Loss of NgR1 decreases axonal collateral branching in the developing LOT. Finally, we examined 
axonal collateral branching in vivo as visualized by DiI staining, in which DiI dye was injected into the OB at 
E18 when LOT axonal branching was developmentally established. In LOTUS− /− mice, collateral branches of 
axons in the LOT were significantly increased when compared to that in wild-type mice (Fig. 6c,f). In contrast, 
collateral branches of the LOT in NgR1− /− mice were significantly decreased in comparison to the wild-type 
mice (Fig. 6d,g). Moreover, we examined the branching points of the LOT in double mutants of LOTUS- and 
NgR1-knockout mice (LOTUS− /− ; NgR1− /− ). Axonal branching of the LOT induced by the loss of LOTUS 
appears to be caused by NgR1-mediated signaling because collateral branches of the LOT were reduced in double 
mutants of LOTUS− /− ; NgR1− /− when compared to that of single mutant LOTUS− /− mice (Fig. 6e,h). These 
results suggest that LOTUS-mediated NgR1 function may regulate axonal branching through modulation of 
Nogo-NgR1 signaling.
Discussion
In this study, we show that endogenous Nogo-A signaling through NgR1 induces axonal branching and that 
developmental up-regulation of Nogo-A promotes collateral formation of the LOT during the late development 
period. Recent studies have shown that Nogo-NgR1 signaling plays a key role in axonal branching16–18. Deng et al. 
Figure 5. NgR1 mediates axonal collateral formation in cultured OB neurons. (a1,b1) Immunostaining of 
β III-tubulin, a neuronal marker. (a2,b2) Immunostaining of Tau-1, an axonal marker in the same cells of (1), 
(a3,b3) merged images of (1) and (2), (a4,b4) and immunostaining of Nogo-A in pseudo-color. (a5,b5) Dashed 
boxes in images of a3 and b3 correspond to images of a5 and b5 at higher magnification, respectively. Arrowheads 
indicate axonal collateral branches. Dissociated OB neurons from E14.5 wild type mice (NgR1+/+) (a) or 
ngr1-deficient mice (NgR1− /− ) (b) were cultured for 7days. Branching points in ngr1-deficient (NgR1−/−) 
mice were decreased in comparison with the wild type. (c) Quantitative analysis of axonal branching points in 
cultured OB neurons. Significance, indicated by (*), was obtained by performing Student’s unpaired t-test. *is 
P = 0.0437 (LOTUS+ /+ versus LOTUS− /− (n = 4)), ** is P = 0.0029 (NgR1+ /+ versus NgR1−/− (n = 3)), and 
comparisons indicated by (†) were obtained by performing a one-way ANOVA test with all pairwise multiple 
comparisons test (Tukey’s test). † is P < 0.05. †† is P < 0.000001. Scale bars: 50 µm.(d) Quantitative analysis of 
axon lengths in cultured OB neurons. Axon lengths of Tau-1-positive neurites were measured using NIH ImageJ 
software. Nogo-A knockdown (sh-Nogo, using sh-1 in LOTUS+ /+ and sh-3 in LOTUS−/−) resulted in the 
increase of axon length. Similarly, axon lengths in ngr1-deficient (NgR1− /− ) mice were increased compared 
to those in the wild-type mice. Significance was obtained by performing one-way ANOVA with Holm-Sidak’s 
multiple comparison test. *P = 0.0192 (control versus sh-Nogo treatment (n = 17–34 axons)); **P = 0.0218  
(wild type versus NgR1− /− (n = 4 littermates)); ***P = 0.0229 (wild type versus LOTUS−/− (n = 5 littermates)).
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reported that axonal branches are reduced in rat embryonic hippocampal neurons cultured on exogenous 
Nogo-A-coated dishes18. Because the methodology in this previous report is different from that used in the cur-
rent study, this finding is inconsistent with our data. In contrast, it has recently been reported that endogenous 
Nogo-A induces axonal branching and inhibits axonal growth in cultured dorsal root ganglion neurons from 
rodents16. Similarly, our data support the hypothesis that Nogo signaling through NgR1 promotes axonal branch-
ing and inhibits axonal growth.
We examined the effect of the loss of endogenously expressed Nogo-A on axonal branching in cultured OB 
neurons by shRNA. When we analyzed the effect of exogenous Nogo-A using Nogo-A-coated beads on cultured 
OB cells, we found no effect of Nogo-A on axonal branching (data not shown). Therefore, the elimination of 
endogenously expressed Nogo-A may efficiently decrease axonal branches in cultured OB neurons. In another 
recent study, inhibition of endogenous Nogo and NgR1 functions by neutralizing antibodies against these mol-
ecules in cultured dorsal root ganglion neurons from rodents resulted in a reduction in axonal branches16. This 
previous report is consistent with our data. Moreover, axonal branches of OB axons were reduced in NgR1− /− 
mice both in vitro and in vivo in this study, suggesting NgR1-mediated signaling is required for axonal branching. 
Taken together, our data suggest that endogenous Nogo-A may induce axonal branching.
We found that loss of LOTUS (in LOTUS− /− ) induced an abnormal increase in axonal branches (Fig. 6c,f), 
whereas simultaneous loss of NgR1 with LOTUS (in LOTUS− /− ; NgR1− /− ) rescued the abnormal increase in 
axonal branches and decreased axonal branches both in vitro and in vivo (Fig. 6e,h). These findings strongly suggest 
that NgR1-mediated signaling induces axonal branching. Although we have not examined nogo-deficient mice in 
vivo due to mouse unavailability, shRNA experiments performed in vitro clearly revealed that Nogo-A is required 
for the induction of axonal branching (Figs 4,5). We confirmed that Nogo-A, NgR1 and LOTUS were expressed 
in the mouse OB after LOT formation (E14), and expression of Nogo-A was up-regulated in the OB (Fig. 2), 
although immunoblotting experiments revealed that the expression levels of LOTUS in the OB almost remained 
Figure 6. Functions of LOTUS and NgR1 in axonal branching of the LOT in vivo. (a) Schematic drawing 
of the lateral view of axonal branching in the LOT. The dashed square indicates the position of branch point 
analysis. (b–e) Lateral views of LOT axonal branching in whole brain from lotus-deficient mice (LOTUS−/−) 
and ngr1-deficient (NgR1− /− ) mice at E18. Compared to wild-type mice (b), the axonal branching points of 
the LOT were increased (white arrowheads) in LOTUS− /− (c), whereas the branching points in NgR1−/− 
were decreased (d). Abnormally increased axonal branching observed in LOTUS− /− was rescued in double 
homozygous mutants of lotus and ngr1 (LOTUS− /− ; NgR1− /− ) (e). Scale bar: 50 µ m. (f–h) Quantitative 
analysis of branching points in the LOT. (f) Comparison of wild-type, LOTUS+ /− and LOTUS−/− mice.  
(g) Comparison of wild-type, NgR1+ /− and NgR1− /− mice. (h) Comparison of wild-type, NgR1+/− and  
NgR1− /− mice in the background of LOTUS− /− mice. Significance, indicated by (*), was analyzed using a 
Tukey’s one-way ANOVA test. (f) * is P = 0.031 (LOTUS+ /+ versus LOTUS−/− (n = 5 littermates)).  
(g) ** is P = 0.00008 (NgR1+ /+ versus NgR1− /− (n = 4 littermates)) and *** is P = 0.0016 (NgR1+/− versus 
NgR1− /− (n = 4 littermates)). (h) **** is P = 0.0001 (LOTUS− /− ; NgR1+ /+ versus LOUTS−/−; NgR1−/− 
(n = 3 littermates)) and ***** is P = 0.0076 (LOTUS− /− ; NgR1+ /+ versus LOTUS−/−; NgR1+/− (n = 3 
littermates)).
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unchanged. Therefore, axonal branching is considered to be developmentally controlled by Nogo-A-NgR1 
signaling exerted by Nogo-A up-regulation and possibly associated with the overcoming of the NgR1 antag-
onistic action of LOTUS. Because Nogo-A showed a spotted expression in axons (Supplementary Fig.S1), 
it is also possible that the acute spatiotemporal increase of Nogo-A in the LOT may induce axonal collateral 
formation and play an important role in the development of the olfactory system. We speculate that during 
the early developmental period (E12-E16), unchanged expression of the three molecules investigated here 
mainly promotes axonal elongation of the LOT; then, during the late developmental period (E17-E18), Nogo-A 
up-regulation in the OB may activate Nogo-A-NgR1 signaling, thereby inducing axonal branching.
A previous study has reported that anosmin-1 encoded by KAL-1, the gene responsible for Kallman syn-
drome, is involved in LOT development. Loss of anosmin-1 induces a reduction in axonal branching in the 
embryonic rat LOT5. It is well known that the Rho family of molecules acts downstream of anosmin-1 signa-
ling21. Therefore, Rho activation may be required for axonal branching in LOT development. In fact, previous 
studies have demonstrated that activation of RhoA induces axonal branching in cortical neurons22 and dorsal 
root ganglion neurons through Nogo-NgR1 signaling. Thus, Nogo-A-mediated RhoA activation induces axonal 
branching because Nogo-NgR1 signaling induces RhoA activation. We speculated that the signaling pathways of 
Nogo-A and anosmin-1 may complement each other to induce axonal branching of LOT.
Nogo-A and NgR1 have been studied extensively in CNS injury and repair. Although it has been shown that 
Nogo-A and NgR1 are expressed in the developing brain, little is known of their physiological functions23. Our 
present study has shown that Nogo-NgR1 signaling is physiologically important in the collateral axonal branch-
ing of LOT in the developing brain.
Methods
Animals. Pregnant C57BL/6 J mice were purchased from Charles River Co. (Japan, Inc.), and lotus/crtac1b 
and ngr1 mutant mice were housed in a standard mouse facility and provided with an autoclaved diet and water. 
Throughout the experimental procedures, all efforts were made to minimize the number of animals used and 
their suffering. The experimental procedures were approved by the institutional animal care and use ethical com-
mittee of Yokohama City University and were carried out in accordance with the approved guidelines. LOTUS 
and NgR1 mutants were assessed in C57BL/6j background. Single mutant mice were bred with each other and 
intercrossed to obtain double heterozygous mice. The respective genotypes were then intercrossed among them-
selves to give more homozygous mutants, single mutants, and wild-type cousins for experimentation.
Antibodies. The monoclonal hamster antibody against mouse-LOTUS (H24G11-mAb)9, monoclonal mouse 
antibody against rat-LOTUS (No.52-1E, ITM), monoclonal hamster antibody against Nogo (NG1-mAb) (kind 
gift from T. Hirata at the National Institute of Genetics, Mishima, Japan)24, and monoclonal guinea pig antibody 
against Tbx21 (kind gift from Y. Yoshihara at the RIKEN Brain Science Institute, Wako, Japan)25 were used. 
The monoclonal mouse antibody against Nogo-A (Millipore, Temecula, CA, USA), polyclonal goat antibody 
against mouse NgR1 (R&D Systems, Minneapolis, MN, USA), polyclonal rabbit antibody against β III-tubulin 
(Genscript, Piscataway, NJ, USA), monoclonal mouse antibody against Tau-1 (Millipore), polyclonal rabbit anti-
body against Tau-1 (Santa Cruz Biotechnology, Dallas, TX, USA), monoclonal mouse antibody against β -actin 
(Sigma-Aldrich, St. Louis, MO, USA), biotinylated goat antibody against hamster IgG (Jackson ImmunoResearch, 
West Grove, PA, USA), Cy3-conjugated goat antibody against hamster IgG (Jackson ImmunoResearch), bioti-
nylated donkey antibody against goat IgG (Jackson ImmunoResearch), Alexa488-labeled goat antibody against 
mouse IgG (Invitrogen, Carlsbad, CA, USA), Alexa488-labeled donkey antibody against guinea pig IgG 
(Jackson ImmunoResearch), Alexa594-labeled goat antibody against mouse IgG (Jackson ImmunoResearch), 
Alexa647-labeled goat antibody against rabbit IgG (Invitrogen), horseradish peroxidase (HRP)-conjugated 
donkey antibody against rabbit IgG (GE Healthcare), HRP-conjugated sheep antibody against mouse IgG (GE 
Healthcare, Chicago, IL, USA), HRP-conjugated donkey antibody against goat IgG (Jackson ImmunoResearch) 
and HRP-conjugated donkey antibody against mouse IgM (Jackson ImmunoResearch) were obtained 
commercially.
Primary dissociated culture of mouse OB neurons. Dissected mouse E14 OBs were dissociated by 
trypsinization with 0.25% trypsin (GIBCO/BRL Life Technologies, Grand Island, New York, USA) for 5 min 
at 37 °C in Hank’s balanced salt solution without Ca2+ and Mg2+ (Invitrogen) and cultured on poly-L-lysine 
(100 µ g/ml, Wako)-coated 96-well plastic culture plates (Greiner Bio-One, Kremsmuenster, Austria) with 
Neurobasal medium (Invitrogen) containing 1% GlutaMax (GIBCO/BRL) and 2% B27 supplement (Invitrogen) 
at a density of 1 × 104 cells per well. The neurons were cultured at 37 °C under 5% CO2 for 7 days.
Immunoblotting. For immunodetection of LOTUS, NgR1 and Nogo-A, sample lysates were prepared 
from the OB from E15, E16, E17 and E18 mouse embryos and P0 postnatal mice. Proteins (20 µ g per lane) 
were subjected to SDS-polyacrylamide gel electrophoresis (8% gel) in Laemmli buffer system. After electropho-
retic transfer to a polyvinylidene fluoride membrane (Millipore), proteins were blocked with 5% skim milk in 
Tris-buffered saline (TBS) containing 0.1% Tween-20 for 1 h at room temperature (RT) and then probed with the 
mouse anti-rat LOTUS antibody (ITM, 1:1000 dilution), anti-NgR1 antibody (R&D Systems, 1:1000 dilution), 
anti-Nogo-A antibody (Millipore, 1:1000 dilution) or anti-β -actin antibody (Sigma-Aldrich, 1:10000 dilution) for 
12 h at 4 °C. Then, they were incubated with HRP-conjugated anti-mouse IgG (GE Healthcare, 1:1000 dilution for 
anti-rat LOTUS antibody, 1:10000 dilution for anti-β -actin antibody), HRP-conjugated anti-goat IgG (Jackson 
ImmunoResearch, 1:1000 dilution), HRP-conjugated anti-mouse IgM antibodies (Jackson ImmunoResearch, 
1:1000 dilution) for 1 h at RT and visualized with the electrochemiluminescence kit (Takara, Kusatsu, Japan; GE 
Healthcare) using an imager (Image Quant 400, GE Healthcare).
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Immunostaining of mouse OB. The dissected embryonic telencephalons were fixed with 4% paraformal-
dehyde (PFA) (Sigma-Aldrich) in phosphate buffered saline (PBS) overnight at 4 °C and immersed in 30% sucrose 
in PBS for 1 day. Coronal sections at 20 µ m in thickness were made with a cryostat (HM550, Thermo Fisher 
Scientific, Waltham, MA, USA). The sections were blocked with 5% normal horse serum (Vector Laboratories, 
Burlingame, CA, USA) in Tris-buffered saline (TBS) containing 0.3% Triton X-100 for 1 h and incubated with 
primary antibodies overnight at room temperature (RT). Primary antibodies used were as follows: guinea pig 
anti-Tbx21 (Yoshihara et al.25, 1:1000 dilution)25, mouse anti-Nogo-A (Tozaki et al.24, 1:100 dilution)24, and DAPI 
(WAKO, Osaka, Japan, 1 µ g/ml). The sections were washed 3 times with TBS containing 0.3% Triton X-100, fol-
lowed by incubation with fluorescence-conjugated secondary antibodies for 1 h at RT. Secondary antibodies used 
were Cy3-conjugated anti-hamster secondary antibodies (1:300 dilution) and Alexa488-conjugated anti-guinea 
pig secondary antibodies (1:300 dilution). The sections were observed by epifluorescence using a microscope 
(IX-73, Olympus, Tokyo, Japan).
Immunostaining of whole-mount forebrain. Telencephalons were fixed with 4% PFA in PBS for 2 h 
at RT, additionally fixed for 1 h at 67 °C to inactivate endogenous alkaline phosphatase (AP), and then washed 
3 times with TBS containing 5% Tween-20 (TBS-T) for 20 min at RT. The specimens were first incubated in 5% 
skim milk in TBS-T for 1 h at RT to block nonspecific binding of antibodies, incubated overnight at 4 °C with 
anti-Nrp1 (Sato et al.9, 1:10000 dilution, 20 nM)9 or anti-LOTUS (Sato et al.9, H24G11-mAb, 1 µ g/ml)9 antibodies, 
and then washed 3 times with TBS-T for 20 min at RT. The specimens were incubated with biotinylated second-
ary antibodies (Jackson ImmunoResearch, 1:5000 dilution) for 2 h at RT and then washed 3 times with TBS-T 
for 20 min at RT, followed by incubation with the Vectastatin ABC-AP kit (Vector Labs., 1:5000 dilution) for 
2 h at RT. After washing with TBS-T 3 times for 20 min at RT, immunodeposits of AP activity were detected by 
color reaction with NBT/BCIP. The specimens were observed using a Leica microscope (MZ-12, Leica, Wetzlar, 
Germany) and digital images were obtained with a CCD camera (DP70, Olympus). In all cases, matched control 
immunostaining was carried out with non-immune IgG or without the presence of the primary antibody.
Immunostaining of mouse OB cultured neurons. The cultured dissociated neurons were fixed in 
warmed 4% PFA in culture medium for 10 min at 37 °C, followed by 10 min at RT. After rinsing with PBS, the 
explants were blocked with 1% bovine serum albumin (Sigma-Aldrich) in PBS containing 0.1% Triton X-100 
for 1 h at RT, probed with primary antibodies against β III-tubulin (Genscript, 0.2 µ g/ml), mouse anti-Tau-1 
(Millipore, 1:1000 dilution) or rabbit anti-Tau-1 (Santa Cruz Biotechnology, 1:100 dilution), Tbx21 (Yoshihara 
et al.25, 1:1000 dilution)25, and mouse anti-Nogo-A (Tozaki et al.24, NG1-mAb, 1:10 dilution)24 overnight at 4 °C, 
and then incubated with fluorescence-conjugated secondary antibodies for 1 h at RT. Cells were observed by 
epifluorescence using a microscope (IX-73, Olympus). Digital images were obtained with a CCD camera (DP80, 
Olympus) and analyzed with a personal computer with MetaMorph (Molecular Devices, Sunnyvale, CA, USA) 
and ImageJ (NIH) software.
DiI tracing. To label the LOT, small crystals of DiI (D3911, Invitrogen) were implanted into the center of the 
OB in E18 mouse embryos fixed with 4% PFA in PBS. The telencephalons were incubated at 37 °C for approxi-
mately 3 weeks. Specimens were observed using a Leica microscope (MZ-12, Leica) and a Keyence microscope 
(BZ-8100, Keyence, Osaka, Japan), and digital images were obtained with a CCD camera (Olympus DP70, 
Olympus).
Collateral branching points in the axons were counted and divided by the total axon length. The collateral 
index was given as the number of branching points (countable branching points over 10 µ m collateral branch) 
per 1 mm of an axon.
Knockdown of mRNA. Lentiviral transduction particles encoding short hairpin RNA (shRNA) 
sequences that silence Nogo-A mRNA expression (GenBank accession number NM_194054.3. Clone ID 
sh1:TRCN0000071688, sh2:TRCN0000375427, sh3:TRCN0000379233, Sigma MISSION shRNA) (Fig. 1S) or do 
not silence the expression of any genes (as negative control: SHC002V, Sigma MISSION shRNA) were purchased 
from Sigma MISSION shRNA–RNA interference as frozen lentivirus stocks. Dissected mouse E14 OB neurons 
were dissociated and cultured at 37 °C for 24 h, exposed to the lentivirus at 1 IU/cell for 6 days, and then fixed and 
immunostained.
Collateral branching points in the axons were counted and divided by the axon length (removed axons under 
100 µ m in length). The collateral index was given as mentioned above.
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Supplementary Figure S1: Nogo-A is expressed in Tbx21- and 
Tau-1-immunopositive cells. Fluorescent immunocytochemistry 
of Tbx21 (a), Nogo-A (b) and Tau-1 (c) in OB cultured neurons. 
Most cells (more than 90%) expressed Nogo-A also co-expressed 
Tbx21 and Tau-1, showing that Nogo-A expressed cells are 
originated from mitral/tufted cell. Bar: 100 µm.  
  
 
   
 
Supplementary Figure S2: shRNA sequences silencing 
Nogo-A mRNA expression. The sequences are expressed by 
lentiviral particles to silence the expression of mouse Nogo-A 
mRNA (NM_194054.3). The numbers described on the left side 
of each sequence show the nucleotides number of NogoA mRNA 
(NM_194054.3) that the shRNA targets. They are cloned in 
shRNA lentivirus vectors and lentiviral particles are provided by 
Sigma (Clone ID sh1:TRCN0000071688, sh2:TRCN0000375427, 
sh3: TRCN0000379233, Sigma MISSION shRNA).  
 
 
 
 
 
No.  Nucleotide number shRNA expression sequence
                                                       sense strand                       loop                anti-sense strand
sh1     3565-3585      CCGGGCAGTGTTGATGTGGGTATTTCTCGAGAAATACCCACATCAACACTGCTTTTTG 
sh2     3411-3431      CCGGCCACCCATTCAGGGCATATTTCTCGAGAAATATGCCCTGAATGGGTGGTTTTTG 
sh3     3676-3696      CCGGCAGGCGCAGATAGATCATTATCTCGAGATAATGATCTATCTGCGCCTGTTTTTG 
Supplementary Figure. S2 
  
Supplementary Figure. S3: Quantitative analysis of Nogo-A 
expression. The expression level of Nogo-A in cultured OB 
neurons was visualized with immunostaining, quantified by 
measuring intracellular luminous intensity with the Metamorph 
software (Molecular Devices) and normalized to the wild-type or 
lotus-knockout neurons exposed to negative-control 
shRNA-expressed virus respectively. Significance was performed 
by Tukey one-way ANOVA test. **P < 0.01 by Tukey one 
way-ANOVA test (NC, negative control versus sh-Nogo-A: 1, 2, 
3).  
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